Global Ankylosing Spondylitis Drug Market Research Report 2019

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Ankylosing Spondylitis Drug Revenue
• 1.4 Market by Type
  • 1.4.1 Global Ankylosing Spondylitis Drug Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Cimzia
  • 1.4.3 Enbrel
  • 1.4.4 Humira
  • 1.4.5 Remicade
  • 1.4.6 Simponi
  • 1.4.7 Others
• 1.5 Market by Application
  • 1.5.1 Global Ankylosing Spondylitis Drug Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Clinics
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Ankylosing Spondylitis Drug Market Perspective (2015-2026)
• 2.2 Global Ankylosing Spondylitis Drug Growth Trends by Regions
  • 2.2.1 Ankylosing Spondylitis Drug Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Ankylosing Spondylitis Drug Historic Market Share by Regions (2015-2020)
  • 2.2.3 Ankylosing Spondylitis Drug Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Ankylosing Spondylitis Drug Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Ankylosing Spondylitis Drug Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Ankylosing Spondylitis Drug Players by Market Size
  • 3.1.1 Global Top Ankylosing Spondylitis Drug Players by Revenue (2015-2020)
  • 3.1.2 Global Ankylosing Spondylitis Drug Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Ankylosing Spondylitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Ankylosing Spondylitis Drug Market Concentration Ratio
  • 3.2.1 Global Ankylosing Spondylitis Drug Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Ankylosing Spondylitis Drug Revenue in 2019
• 3.3 Ankylosing Spondylitis Drug Key Players Head office and Area Served
• 3.4 Key Players Ankylosing Spondylitis Drug Product Solution and Service
• 3.5 Date of Enter into Ankylosing Spondylitis Drug Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Ankylosing Spondylitis Drug Historic Market Size by Type (2015-2020)
• 4.2 Global Ankylosing Spondylitis Drug Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Ankylosing Spondylitis Drug Market Size by Application (2015-2020)
• 5.2 Global Ankylosing Spondylitis Drug Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Ankylosing Spondylitis Drug Market Size (2015-2020)
• 6.2 Ankylosing Spondylitis Drug Key Players in North America (2019-2020)
• 6.3 North America Ankylosing Spondylitis Drug Market Size by Type (2015-2020)
• 6.4 North America Ankylosing Spondylitis Drug Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Ankylosing Spondylitis Drug Market Size (2015-2020)
• 7.2 Ankylosing Spondylitis Drug Key Players in Europe (2019-2020)
• 7.3 Europe Ankylosing Spondylitis Drug Market Size by Type (2015-2020)
• 7.4 Europe Ankylosing Spondylitis Drug Market Size by Application (2015-2020)

8 China

• 8.1 China Ankylosing Spondylitis Drug Market Size (2015-2020)
• 8.2 Ankylosing Spondylitis Drug Key Players in China (2019-2020)
• 8.3 China Ankylosing Spondylitis Drug Market Size by Type (2015-2020)
• 8.4 China Ankylosing Spondylitis Drug Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Ankylosing Spondylitis Drug Market Size (2015-2020)
• 9.2 Ankylosing Spondylitis Drug Key Players in Japan (2019-2020)
• 9.3 Japan Ankylosing Spondylitis Drug Market Size by Type (2015-2020)
• 9.4 Japan Ankylosing Spondylitis Drug Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Ankylosing Spondylitis Drug Market Size (2015-2020)
• 10.2 Ankylosing Spondylitis Drug Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Ankylosing Spondylitis Drug Market Size by Type (2015-2020)
• 10.4 Southeast Asia Ankylosing Spondylitis Drug Market Size by Application (2015-2020)

11 India

• 11.1 India Ankylosing Spondylitis Drug Market Size (2015-2020)
• 11.2 Ankylosing Spondylitis Drug Key Players in India (2019-2020)
• 11.3 India Ankylosing Spondylitis Drug Market Size by Type (2015-2020)
• 11.4 India Ankylosing Spondylitis Drug Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Ankylosing Spondylitis Drug Market Size (2015-2020)
• 12.2 Ankylosing Spondylitis Drug Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Ankylosing Spondylitis Drug Market Size by Type (2015-2020)
• 12.4 Central & South America Ankylosing Spondylitis Drug Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Amgen
  • 13.1.1 Amgen Company Details
  • 13.1.2 Amgen Business Overview
  • 13.1.3 Amgen Ankylosing Spondylitis Drug Introduction
  • 13.1.4 Amgen Revenue in Ankylosing Spondylitis Drug Business (2015-2020))
  • 13.1.5 Amgen Recent Development
• 13.2 Wyeth
  • 13.2.1 Wyeth Company Details
  • 13.2.2 Wyeth Business Overview
  • 13.2.3 Wyeth Ankylosing Spondylitis Drug Introduction
  • 13.2.4 Wyeth Revenue in Ankylosing Spondylitis Drug Business (2015-2020)
  • 13.2.5 Wyeth Recent Development
• 13.3 Takeda
  • 13.3.1 Takeda Company Details
  • 13.3.2 Takeda Business Overview
  • 13.3.3 Takeda Ankylosing Spondylitis Drug Introduction
  • 13.3.4 Takeda Revenue in Ankylosing Spondylitis Drug Business (2015-2020)
  • 13.3.5 Takeda Recent Development
• 13.4 Centocor
  • 13.4.1 Centocor Company Details
  • 13.4.2 Centocor Business Overview
  • 13.4.3 Centocor Ankylosing Spondylitis Drug Introduction
  • 13.4.4 Centocor Revenue in Ankylosing Spondylitis Drug Business (2015-2020)
  • 13.4.5 Centocor Recent Development
• 13.5 Schering-Plough
  • 13.5.1 Schering-Plough Company Details
  • 13.5.2 Schering-Plough Business Overview
  • 13.5.3 Schering-Plough Ankylosing Spondylitis Drug Introduction
  • 13.5.4 Schering-Plough Revenue in Ankylosing Spondylitis Drug Business (2015-2020)
  • 13.5.5 Schering-Plough Recent Development
• 13.6 Mitsubishi Tanabe
  • 13.6.1 Mitsubishi Tanabe Company Details
  • 13.6.2 Mitsubishi Tanabe Business Overview
  • 13.6.3 Mitsubishi Tanabe Ankylosing Spondylitis Drug Introduction
  • 13.6.4 Mitsubishi Tanabe Revenue in Ankylosing Spondylitis Drug Business (2015-2020)
  • 13.6.5 Mitsubishi Tanabe Recent Development
• 13.7 Abbott
  • 13.7.1 Abbott Company Details
  • 13.7.2 Abbott Business Overview
  • 13.7.3 Abbott Ankylosing Spondylitis Drug Introduction
  • 13.7.4 Abbott Revenue in Ankylosing Spondylitis Drug Business (2015-2020)
  • 13.7.5 Abbott Recent Development
• 13.8 Eisai
  • 13.8.1 Eisai Company Details
  • 13.8.2 Eisai Business Overview
  • 13.8.3 Eisai Ankylosing Spondylitis Drug Introduction
  • 13.8.4 Eisai Revenue in Ankylosing Spondylitis Drug Business (2015-2020)
  • 13.8.5 Eisai Recent Development
• 13.9 Pfizer
  • 13.9.1 Pfizer Company Details
  • 13.9.2 Pfizer Business Overview
  • 13.9.3 Pfizer Ankylosing Spondylitis Drug Introduction
  • 13.9.4 Pfizer Revenue in Ankylosing Spondylitis Drug Business (2015-2020)
  • 13.9.5 Pfizer Recent Development
• 13.10 Johnson & Johnson
  • 13.10.1 Johnson & Johnson Company Details
  • 13.10.2 Johnson & Johnson Business Overview
  • 13.10.3 Johnson & Johnson Ankylosing Spondylitis Drug Introduction
  • 13.10.4 Johnson & Johnson Revenue in Ankylosing Spondylitis Drug Business (2015-2020)
  • 13.10.5 Johnson & Johnson Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer